NON-INVASIVE CANCER SOLUTIONS     
Safe | Accurate | Easy on the Patient

PROBLEM STATEMENTS ON OUR TARGET

  • There is an urgent, unmet need for a blood based, non-invasive, accurate, cost-effective screening test for cancer that will even determine the probable location of the tumor.
  • Cancer biopsies for obtaining tissue for diagnosis (when a lesion is detected) are painful, risky, clinic centric, inaccurate in many instances and types of cancer, impossible in many individuals and very costly in many organ types such as colon, stomach, lung, pancreas etc.
  • Biopsies for brain lesions are extremely risky (mortality / permanent morbidity risk >15%), expensive and often times indeterminate. Also, they can be performed only at specialized centers.
  • Treatment options for patients with drug resistant cancer diminish rapidly and is the end of the road for such patients.
  • Monitoring drug resistance in ongoing treatment of cancer patients is impossible and is the sole cause for recurrence.
TRIALS
Sr. No. Name of Trial CTRI Link Status
1 RESILIENT CTRI/2018/02/011808

Closed
Data Published in
Oncotarget

2 RESOLUTE CTRI/2019/01/017219

Ongoing
Intermediate Data Published in
IJC (International Journal of Cancer)

3 TRUBLOOD

CTRI/2019/01/017219
CTRI/2019/03/017918

Ongoing
Intermediate Data Published in
Trublood : Publications

4 LIQUID-IMPACT CTRI/2019/02/017548

Ongoing
Recruitment Ended

We are open to receive proposals for collaborative research in any of the above areas of cancer science from qualified researchers.

CONTACT US

Please contact us for more details.

I have read and understood the terms of use and the privacy policy and I agree.